| Disease‐specific phenotypes in dopamine neurons from human iPS‐based models of genetic and sporadic Parkinson's disease A Sánchez‐Danés, Y Richaud‐Patin, I Carballo‐Carbajal, ... EMBO molecular medicine 4 (5), 380-395, 2012 | 643 | 2012 |
| Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease JM Canals, JR Pineda, JF Torres-Peraza, M Bosch, R Martín-Ibañez, ... Journal of Neuroscience 24 (35), 7727-7739, 2004 | 416 | 2004 |
| Heterochronic mechanisms of morphological diversification and evolutionary change in the neotropical salamander, Bolitoglossa occidentalis (Amphibia … P Alberch, J Alberch Journal of Morphology 167 (2), 249-264, 1981 | 287 | 1981 |
| Altered P2X7‐receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration M Díaz-Hernández, M Díez-Zaera, J Sánchez-Nogueiro, ... The FASEB Journal 23 (6), 1893-1906, 2009 | 273 | 2009 |
| Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase M Borrell-Pagès, JM Canals, FP Cordelières, JA Parker, JR Pineda, ... The Journal of clinical investigation 116 (5), 1410-1424, 2006 | 265 | 2006 |
| Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease C Blazquez, A Chiarlone, O Sagredo, T Aguado, MR Pazos, E Resel, ... Brain 134 (1), 119-136, 2011 | 238 | 2011 |
| Glial cell line-derived neurotrophic factor promotes the survival and morphologic differentiation of Purkinje cells. HTJ Mount, DO Dean, J Alberch, CF Dreyfus, IB Black Proceedings of the National Academy of Sciences 92 (20), 9092-9096, 1995 | 226 | 1995 |
| Brain‐derived neurotrophic factor, neurotrophin‐3, and neurotrophin‐4/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease E Pérez‐Navarro, AM Canudas, P Åkerud, J Alberch, E Arenas Journal of neurochemistry 75 (5), 2190-2199, 2000 | 225 | 2000 |
| Differential effects of glial cell line‐derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons P Åkerud, J Alberch, S Eketjäll, J Wagner, E Arenas Journal of neurochemistry 73 (1), 70-78, 1999 | 222 | 1999 |
| Mutant huntingtin impairs post-Golgi trafficking to lysosomes by delocalizing optineurin/Rab8 complex from the Golgi apparatus D Del Toro, J Alberch, F Lázaro-Diéguez, R Martín-Ibáñez, X Xifro, ... Molecular biology of the cell 20 (5), 1478-1492, 2009 | 209 | 2009 |
| Conditional BDNF delivery from astrocytes rescues memory deficits, spine density, and synaptic properties in the 5xFAD mouse model of Alzheimer disease B de Pins, C Cifuentes-Díaz, AT Farah, L López-Molina, E Montalban, ... Journal of Neuroscience 39 (13), 2441-2458, 2019 | 200 | 2019 |
| Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice Nature neuroscience 20 (5), 648-660, 2017 | 192 | 2017 |
| The expanding clinical profile of anti-AMPA receptor encephalitis F Graus, A Boronat, X Xifro, M Boix, V Svigelj, A Garcia, A Palomino, ... Neurology 74 (10), 857-859, 2010 | 172 | 2010 |
| Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity A Giralt, M Puigdellivol, O Carretón, P Paoletti, J Valero, A Parra-Damas, ... Human molecular genetics 21 (6), 1203-1216, 2012 | 169 | 2012 |
| Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain S Ginés, M Bosch, S Marco, N Gavalda, M Díaz‐Hernández, JJ Lucas, ... European Journal of Neuroscience 23 (3), 649-658, 2006 | 165 | 2006 |
| BDNF up‐regulates TrkB protein and prevents the death of CA1 neurons following transient forebrain ischemia I Ferrer, J Ballabriga, E Martí, E Pérez, J Alberch, E Arenas Brain pathology 8 (2), 253-261, 1998 | 163 | 1998 |
| Dopaminergic and glutamatergic signaling crosstalk in Huntington's disease neurodegeneration: the role of p25/cyclin-dependent kinase 5 P Paoletti, I Vila, M Rifé, JM Lizcano, J Alberch, S Ginés Journal of Neuroscience 28 (40), 10090-10101, 2008 | 152 | 2008 |
| Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington’s disease J Alberch, E Perez-Navarro, JM Canals Brain research bulletin 57 (6), 817-822, 2002 | 152 | 2002 |
| Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients R Fernández‐Santiago, I Carballo‐Carbajal, G Castellano, R Torrent, ... EMBO molecular medicine 7 (12), 1529-1546, 2015 | 149 | 2015 |
| Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease A Giralt, A Saavedra, O Carreton, X Xifro, J Alberch, E Perez-Navarro Human molecular genetics 20 (21), 4232-4247, 2011 | 139 | 2011 |
